Yen et al. reported that the HBx-activated mTOR signaling proceeds via IκB kinase β (IKKβ) and increases cell proliferation and vascular endothelial growth factor (VEGF) production during HCC development [28]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.